Dimethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isophthalate, 95.0%, 10g

Mal-PEG4-Val-Cit-PAB-PNP, 100mg

(S)-2-Amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid hydrochloride, 95.0%, 250mg

(S)-Morpholin-3-ylmethanol hydrochloride, 95.0%, 10g

6-Benzyl-6,7-dihydro-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,5H)-dione, 95.0%, 1g

4-Chloro-5-hydroxypyridazin-3(2H)-one, 95.0%, 250mg

3-Phenyl-3-(trifluoromethyl)-3H-diazirine>98.0%(HPLC)1g

1-(tert-Butoxycarbonyl)-3-hydroxyazetidine>96.0%(GC)1g

(4aR,8aR)-Ethyl 7-oxooctahydro-2H-pyrano[3,2-c]pyridine-4a-carboxylate, 95%, 500mg

1-Bromo-3-chloro-5-isopropylbenzene, 97%, 5g

N-(2-Aminophenyl)cyclopropanesulfonamide, 98%, 100mg

2-amino-5,6,7,8-tetrahydro-4-quinazolinol, 95.0%, 1g

(R,R'')-2,2''-Bis(diphenylphosphino)-1,1''-biferrocene>98.0%(T)500mg